OXCARBAZEPINE
- Product NDC
- 60505-4128
- 11-digit product format
- 605054128
- Labeler code
- 60505
- Product ID
- 60505-4128_f106ef3d-7def-b2e5-2428-60ecd16326f0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- OXCARBAZEPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA213369
- Marketing category
- ANDA
- Marketing start
- 2024-09-03
- Substance
- OXCARBAZEPINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213369-001 | OXCARBAZEPINE | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | |
| A213369-002 | OXCARBAZEPINE | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | |
| A213369-003 | OXCARBAZEPINE | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213369-001 | AB |
| A213369-002 | AB |
| A213369-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2023-07-13 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213369-002 | OXCARBAZEPINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A213369-003 | OXCARBAZEPINE | 600MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A213369-001 | OXCARBAZEPINE | 150MG | TABLET, EXTENDED RELEASE / ORAL | 2023-07-13 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A213369-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213369-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213369-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213369-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213369-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213369-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213369-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A213369-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A213369-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A213369-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A213369-003 | AB | 1 | d06236e962d9… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213369-001 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213369-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A213369-003 | AB | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OXCARBAZEPINE
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXCARBAZEPINE | 150 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| VZI5B1W380 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a20e4a95-8ee1-e702-003e-e353ec1ee133 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ca2a6da1-5711-44d0-9e79-c84d4265f98b | Product name | 3 | 20250724 |
| 536d5b6b-66f1-478b-2670-88fd15947e3b | Product name | 7 | 20250218 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-4128-5 | OXCARBAZEPINE | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | 6 | |
| 60505-4128-7 | OXCARBAZEPINE | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-4128-7 | EA - Each | 60505-4128 | 089b4718-99de-4c5c-8718-f383d29c2b34 | 1 | 2024-09-09 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-4128 | OXCARBAZEPINE TABLET, EXTENDED RELEASE [APOTEX CORP.] | 5 | Current NDC, 2 package rows | 20240913_a20e4a95-8ee1-e702-003e-e353ec1ee133.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | Apotex Corp. | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 2025-09-19 | Warnings, Adverse reactions | 213369 ANDA213369 60505-4128 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1365653 | OXcarbazepine 150 MG 24HR Extended Release Oral Tablet | PSN | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365842 | OXcarbazepine 300 MG 24HR Extended Release Oral Tablet | PSN | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365844 | OXcarbazepine 600 MG 24HR Extended Release Oral Tablet | PSN | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365653 | 24 HR oxcarbazepine 150 MG Extended Release Oral Tablet | SCD | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365842 | 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet | SCD | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365844 | 24 HR oxcarbazepine 600 MG Extended Release Oral Tablet | SCD | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365653 | oxcarbazepine 150 MG 24 HR Extended Release Oral Tablet | SY | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365842 | oxcarbazepine 300 MG 24 HR Extended Release Oral Tablet | SY | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
| 1365844 | oxcarbazepine 600 MG 24 HR Extended Release Oral Tablet | SY | a20e4a95-8ee1-e702-003e-e353ec1ee133 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 60505-4128-5 | 60505412805 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4128-5) | 2024-09-03 | No | No | Current |
| 60505-4128-7 | 60505412807 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4128-7) | 2024-09-03 | No | No | Current |